2016
Epithelial-mesenchymal transition-associated microRNA/mRNA signature is linked to metastasis and prognosis in clear-cell renal cell carcinoma
MLČOCHOVÁ, Hana; Táňa MACHÁČKOVÁ; Anja RABIEN; Lenka RADOVÁ; Pavel FABIAN et. al.Základní údaje
Originální název
Epithelial-mesenchymal transition-associated microRNA/mRNA signature is linked to metastasis and prognosis in clear-cell renal cell carcinoma
Autoři
MLČOCHOVÁ, Hana; Táňa MACHÁČKOVÁ; Anja RABIEN; Lenka RADOVÁ; Pavel FABIAN; Robert ILIEV; Kateřina SLABÁ; Alexandr POPRACH; Ergin KILIC; Michal STANIK; Martina LOJOVÁ; Marek SVOBODA; Jan DOLEZEL; Rostislav VYZULA; Klaus JUNG a Ondřej SLABÝ
Vydání
Scientific Reports, LONDON, NATURE PUBLISHING GROUP, 2016, 2045-2322
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30200 3.2 Clinical medicine
Stát vydavatele
Velká Británie a Severní Irsko
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 4.259
Kód RIV
RIV/00216224:14740/16:00088919
Organizační jednotka
Středoevropský technologický institut
UT WoS
000381767500001
EID Scopus
2-s2.0-84983609876
Klíčová slova anglicky
CANCER; GENE; EXPRESSION; PATHWAYS; TARGETS; PROTEIN; FREM1
Štítky
Příznaky
Recenzováno
Změněno: 26. 4. 2021 13:30, Mgr. Tereza Miškechová
Anotace
V originále
Clear-cell renal cell carcinomas (ccRCCs) are genetically heterogeneous tumors presenting diverse clinical courses. Epithelial-mesenchymal transition (EMT) is a crucial process involved in initiation of metastatic cascade. The aim of our study was to identify an integrated miRNA/mRNA signature associated with metastasis and prognosis in ccRCC through targeted approach based on analysis of miRNAs/mRNAs associated with EMT. A cohort of 230 ccRCC was included in our study and further divided into discovery, training and validation cohorts. EMT markers were evaluated in ccRCC tumor samples, which were grouped accordingly to EMT status. By use of large-scale miRNA/mRNA expression profiling, we identified miRNA/mRNA with significantly different expression in EMT-positive tumors and selected 41 miRNAs/mRNAs for training phase of the study to evaluate their diagnostic and prognostic potential. Fifteen miRNAs/mRNAs were analyzed in the validation phase, where all evaluated miRNA/mRNA candidates were confirmed to be significantly deregulated in tumor tissue. Some of them significantly differed in metastatic tumors, correlated with clinical stage, with Fuhrman grade and with overall survival. Further, we established an EMT-based stage-independent prognostic scoring system enabling identification of ccRCC patients at high-risk of cancer-related death. Finally, we confirmed involvement of miR-429 in EMT regulation in RCC cells in vitro.
Návaznosti
| LQ1601, projekt VaV |
| ||
| NT13547, projekt VaV |
| ||
| 90089, velká výzkumná infrastruktura |
|